CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 45 filers reported holding CTI BIOPHARMA CORP in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $375,858 | -15.6% | 89,490 | +20.7% | 0.00% | – |
| Q4 2022 | $445,539 | +14751.3% | 74,133 | +12860.3% | 0.00% | – |
| Q3 2022 | $3,000 | – | 572 | +1143.5% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 46 | -99.7% | 0.00% | – |
| Q1 2021 | $41,000 | +272.7% | 14,117 | +12.5% | 0.00% | – |
| Q2 2019 | $11,000 | -57.7% | 12,549 | -52.3% | 0.00% | – |
| Q1 2019 | $26,000 | -76.4% | 26,310 | +18.3% | 0.00% | – |
| Q2 2018 | $110,000 | +155.8% | 22,233 | +100.5% | 0.00% | – |
| Q1 2018 | $43,000 | – | 11,090 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 6,535,674 | $27,449,831 | 9.21% |
| Bleichroeder LP | 3,893,730 | $16,353,666 | 3.49% |
| AIGH Capital Management LLC | 2,100,000 | $8,820,000 | 3.25% |
| Ally Bridge Group (NY) LLC | 550,000 | $2,310,000 | 3.03% |
| Ghost Tree Capital, LLC | 2,000,000 | $8,400,000 | 2.48% |
| Bain Capital Life Sciences Investors, LLC | 4,702,996 | $19,753 | 2.47% |
| Altium Capital Management LP | 850,000 | $3,570,000 | 1.98% |
| Parkman Healthcare Partners LLC | 1,753,630 | $7,365,246 | 1.60% |
| BVF INC/IL | 8,813,021 | $37,014,688 | 1.35% |
| Sio Capital Management, LLC | 526,239 | $2,210,204 | 1.09% |